ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.59 Million USD | 0.07% |
| 2022 | -2.89 Million USD | 5.08% |
| 2021 | -3.04 Million USD | -5264.17% |
| 2020 | -56.77 Thousand USD | -40.42% |
| 2019 | -40.43 Thousand USD | 47.41% |
| 2018 | -76.87 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -193.23 Thousand USD | 75.36% |
| 2024 Q2 | -50.65 Thousand USD | 88.11% |
| 2023 Q3 | -757.96 Thousand USD | -15.19% |
| 2023 Q2 | -658.03 Thousand USD | 2.78% |
| 2023 FY | -2.88 Million USD | 0.07% |
| 2023 Q1 | -676.86 Thousand USD | -375.55% |
| 2023 Q4 | -803 Thousand USD | -5.94% |
| 2022 Q4 | -142.33 Thousand USD | 90.2% |
| 2022 FY | -2.89 Million USD | 5.08% |
| 2022 Q3 | -1.45 Million USD | 26.21% |
| 2022 Q2 | -1.96 Million CAD | -637.73% |
| 2022 Q1 | -266.79 Thousand CAD | 88.28% |
| 2021 Q2 | 113.45 Thousand CAD | 109.24% |
| 2021 Q1 | -1.22 Million CAD | -3474.54% |
| 2021 Q3 | 570.88 Thousand CAD | 403.19% |
| 2021 FY | -3.04 Million USD | -5264.17% |
| 2021 Q4 | -2.27 Million USD | -498.68% |
| 2020 Q3 | -12 Thousand CAD | 0.0% |
| 2020 Q1 | -14 Thousand CAD | -3.58% |
| 2020 FY | -56.77 Thousand USD | -40.42% |
| 2020 Q4 | -34.33 Thousand CAD | -186.1% |
| 2020 Q2 | -12 Thousand CAD | 14.29% |
| 2019 Q4 | -13.51 Thousand CAD | -2.28% |
| 2019 FY | -40.43 Thousand USD | 47.41% |
| 2019 Q3 | -13.21 Thousand CAD | -10.47% |
| 2019 Q2 | -11.96 Thousand CAD | 12.9% |
| 2019 Q1 | -13.73 Thousand CAD | 0.0% |
| 2018 FY | -76.87 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -108.73% |
| Arrayit Corporation | -3.62 Million USD | 28.436% |
| Atlantic International Corp. | -5.73 Million USD | 54.777% |
| Biocept, Inc. | -31.98 Million USD | 91.894% |
| Bioqual, Inc. | -19.63 Thousand USD | -13101.08% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -235.745% |
| DermTech, Inc. | -103.73 Million USD | 97.501% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.104% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 87.554% |
| iMD Companies, Inc. | -175.44 Thousand USD | -1377.622% |
| IDenta Corp. | -1499.00 USD | -172843.829% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 192.455% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 6800.512% |
| InVitro International | -25.33 Thousand USD | -10130.98% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 63.6% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -4361.089% |
| Medical Imaging Corp. | -819.48 Thousand USD | -216.35% |
| NovelStem International Corp. | -3.52 Million USD | 26.473% |
| Optigenex Inc. | 1.39 Million USD | 286.394% |
| PharmChem, Inc. | 973.14 Thousand USD | 366.396% |
| Proteome Sciences plc | -1.62 Million USD | -59.928% |
| Response Genetics, Inc | -21.37 Million USD | 87.873% |
| Rennova Health, Inc. | -1.4 Million USD | -83.921% |
| RushNet, Inc. | -684.7 Thousand USD | -278.62% |
| Stella Diagnostics Inc. | -11.42 Million USD | 77.313% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 66.535% |
| Todos Medical Ltd. | -9.74 Million USD | 73.406% |